{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:08:46Z","timestamp":1792112926237,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.biopsych.2006.11.021","type":"journal-article","created":{"date-parts":[[2007,4,19]],"date-time":"2007-04-19T11:28:22Z","timestamp":1176982102000},"page":"652-657","source":"Crossref","is-referenced-by-count":217,"title":["N-Acetyl Cysteine, a Glutamate-Modulating Agent, in the Treatment of Pathological Gambling: A Pilot Study"],"prefix":"10.1016","volume":"62","author":[{"given":"Jon E.","family":"Grant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suck Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Odlaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2006.11.021_bib1","series-title":"Pathological Gambling: A Clinical Guide to Treatment","first-page":"39","article-title":"Clinical characteristics","author":"Argo","year":"2004"},{"key":"10.1016\/j.biopsych.2006.11.021_bib2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1196\/annals.1300.023","article-title":"N-acetyl cysteine-induced blockade of cocaine-induced reinstatement","volume":"1003","author":"Baker","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biopsych.2006.11.021_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0278-5846(00)00146-9","article-title":"On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive compulsive disorder and attention deficit hyperactivity disorder","volume":"25","author":"Carlsson","year":"2001","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2006.11.021_bib4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.biopsych.2005.04.043","article-title":"Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: An open-label trial","volume":"58","author":"Coric","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2006.11.021_bib5","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2105\/AJPH.88.7.1093","article-title":"Taking chances: Problem gamblers and mental health disorders\u2014results from the St. Louis Epidemiologic Catchment Area study","volume":"88","author":"Cunningham-Williams","year":"1998","journal-title":"Am J Public Health"},{"key":"10.1016\/j.biopsych.2006.11.021_bib6","series-title":"Structured Clinical Interview for DSM-IV-Patient Edition (SCID-I\/P, Version 2.0)","author":"First","year":"1995"},{"key":"10.1016\/j.biopsych.2006.11.021_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1037\/1040-3590.4.1.92","article-title":"Clinical validation of the Quality of Life Inventory: A measure of life satisfaction for use in treatment planning and outcome assessment","volume":"4","author":"Frisch","year":"1993","journal-title":"Psychol Assess"},{"key":"10.1016\/j.biopsych.2006.11.021_bib8","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1176\/appi.ajp.159.10.1642","article-title":"Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex","volume":"159","author":"Goldstein","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2006.11.021_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.comppsych.2004.07.022","article-title":"Quality of life in kleptomania and pathological gambling","volume":"46","author":"Grant","year":"2005","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.biopsych.2006.11.021_bib10","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1176\/appi.ajp.162.11.2184","article-title":"Impulse control disorders in adult psychiatric inpatients","volume":"162","author":"Grant","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2006.11.021_bib11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.psc.2006.02.002","article-title":"Compulsive aspects of impulse control disorders","volume":"29","author":"Grant","year":"2006","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.biopsych.2006.11.021_bib12","doi-asserted-by":"crossref","unstructured":"Grant JE, Potenza MN (in press): Treatments for Pathological Gambling and Other Impulse Control Disorders. In: Nathan PE, Gorman JM, editors. A Guide to Treatments that Work, 3rded. New York: Oxford University Press.","DOI":"10.1093\/med:psych\/9780195304145.003.0020"},{"key":"10.1016\/j.biopsych.2006.11.021_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ajp.163.2.303","article-title":"A multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling","volume":"163","author":"Grant","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2006.11.021_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.psychres.2004.05.006","article-title":"Preliminary validity and reliability testing of a structured clinical interview for pathological gambling (SCI-PG)","volume":"128","author":"Grant","year":"2004","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2006.11.021_bib15","first-page":"218","article-title":"ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education and Welfare publication (ADM) 76\u2013338","author":"Guy","year":"1976"},{"key":"10.1016\/j.biopsych.2006.11.021_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychiatry"},{"key":"10.1016\/j.biopsych.2006.11.021_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.biopsych.2006.11.021_bib18","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/j.1471-4159.2005.03517.x","article-title":"Cocaine-induced alterations in nucleus accumbens ionotropic glutamate receptor subunits in human and non-human primates","volume":"95","author":"Hemby","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2006.11.021_bib19","series-title":"Pathological Gambling: A Clinical Guide to Treatment","first-page":"169","article-title":"Cognitive and behavioral treatments","author":"Hodgins","year":"2004"},{"key":"10.1016\/j.biopsych.2006.11.021_bib20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0006-3223(00)00241-9","article-title":"A randomized double-blind fluvoxamine\/placebo crossover trial in pathological gambling","volume":"47","author":"Hollander","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2006.11.021_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1176\/appi.ajp.162.1.137","article-title":"Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?","volume":"162","author":"Hollander","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2006.11.021_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/15622970510029768","article-title":"Imaging monetary reward in pathological gamblers","volume":"6","author":"Hollander","year":"2005","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2006.11.021_bib23","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1176\/appi.ajp.162.8.1403","article-title":"The neural basis of addiction: A pathology of motivation and choice","volume":"162","author":"Kalivas","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2006.11.021_bib24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.neuron.2005.02.005","article-title":"Unmanageable motivation in addiction: A pathology in prefrontal\u2013accumbens glutamate transmission","volume":"45","author":"Kalivas","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2006.11.021_bib25","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0006-3223(01)01079-4","article-title":"Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling","volume":"49","author":"Kim","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2006.11.021_bib26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00213-005-0246-6","article-title":"N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder","volume":"184","author":"Lafleur","year":"2006","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.biopsych.2006.11.021_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/10550490500419169","article-title":"Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals","volume":"15","author":"LaRowe","year":"2006","journal-title":"Am J Addict"},{"key":"10.1016\/j.biopsych.2006.11.021_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.comppsych.2004.07.020","article-title":"Cluster analysis of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder: Clinical and genetic correlates","volume":"46","author":"Lochner","year":"2005","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.biopsych.2006.11.021_bib29","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1523\/JNEUROSCI.23-08-03531.2003","article-title":"Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior","volume":"23","author":"McFarland","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2006.11.021_bib30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10899-005-5557-3","article-title":"Reliability and validity of the Pathological Gambling Modification of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS)","volume":"21","author":"Pallanti","year":"2005","journal-title":"J Gambling Stud"},{"key":"10.1016\/j.biopsych.2006.11.021_bib31","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/archfami.8.6.515","article-title":"Prevalence of gambling disorders in a primary care setting","volume":"8","author":"Pasternak","year":"1999","journal-title":"Arch Fam Med"},{"key":"10.1016\/j.biopsych.2006.11.021_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00213-006-0372-9","article-title":"The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine- and food-seeking behavior in rats","volume":"186","author":"Peters","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2006.11.021_bib33","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1525-1497.2002.10812.x","article-title":"Gambling: an addictive behavior with health and primary care implications","volume":"17","author":"Potenza","year":"2002","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.biopsych.2006.11.021_bib34","series-title":"Designing and Conducting Survey Research","author":"Rea","year":"1992"},{"key":"10.1016\/j.biopsych.2006.11.021_bib35","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1523\/JNEUROSCI.17-21-08491.1997","article-title":"Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine","volume":"17","author":"Robinson","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2006.11.021_bib36","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2105\/AJPH.89.9.1369","article-title":"Estimating the prevalence of disordered gambling behavior in the United States and Canada: A research synthesis","volume":"89","author":"Shaffer","year":"1999","journal-title":"Am J Pub Health"},{"key":"10.1016\/j.biopsych.2006.11.021_bib37","series-title":"The Anxiety Disease","author":"Sheehan","year":"1983"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322306015101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322306015101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T11:33:05Z","timestamp":1556364785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322306015101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0006322306015101"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2006.11.021","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}